SMTL ID : 7s84.1

Crystal structure of CDK2 liganded with compound TW8972

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x 8IL: 2-{[2-(1H-indol-3-yl)ethyl]amino}-5-(trifluoromethyl)benzoic acid(Non-covalent)

8IL.1: 17 residues within 4Å: Chain A: Y.15, K.33, I.52, L.55, L.58, I.63, V.64, L.76, L.78, F.80, C.118, V.123, D.145, F.146, L.148, A.149, F.152 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:L.55, A:I.63, A:L.78, A:F.80, A:V.123, A:F.146, A:F.146, A:F.146, A:L.148 Hydrogen bonds: A:L.58, A:D.145, A:F.146 Water bridges: A:K.33, A:K.33, A:K.33, A:K.33, A:L.66 Salt bridges: A:K.33

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Faber, E.B. et al., Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding. Nat Commun (2023)

Release Date

2022-09-28

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence